Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Gains from Sales and Divestitures (2021 - 2025)

Historic Gains from Sales and Divestitures for Accendra Health (ACH) over the last 9 years, with Q3 2025 value amounting to $652000.0.

  • Accendra Health's Gains from Sales and Divestitures fell 283.16% to $652000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $652000.0, marking a year-over-year decrease of 283.16%. This contributed to the annual value of $1.1 million for FY2024, which is 3640.55% down from last year.
  • Latest data reveals that Accendra Health reported Gains from Sales and Divestitures of $652000.0 as of Q3 2025, which was down 283.16% from $559000.0 recorded in Q2 2025.
  • Over the past 5 years, Accendra Health's Gains from Sales and Divestitures peaked at $2.7 million during Q4 2022, and registered a low of $559000.0 during Q2 2025.
  • Over the past 5 years, Accendra Health's median Gains from Sales and Divestitures value was $887500.0 (recorded in 2024), while the average stood at $1.2 million.
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first surged by 4808.44% in 2022, then plummeted by 3640.55% in 2024.
  • Quarter analysis of 5 years shows Accendra Health's Gains from Sales and Divestitures stood at $1.8 million in 2021, then skyrocketed by 48.08% to $2.7 million in 2022, then tumbled by 34.91% to $1.7 million in 2023, then tumbled by 36.41% to $1.1 million in 2024, then plummeted by 40.94% to $652000.0 in 2025.
  • Its last three reported values are $652000.0 in Q3 2025, $559000.0 for Q2 2025, and $1.1 million during Q4 2024.